版本:
中国

BRIEF-Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil

Oct 7 Neptune Technologies & Bioressources Inc

* Terms also cover potential collaboration between both companies on clinical trials

* Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential

* Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil

* All other terms of agreement remain confidential.

* Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide

* Says agreement is valid till 2028 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐